These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 816124)

  • 41. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.
    Kozel TR; Murphy WJ; Brandt S; Blazar BR; Lovchik JA; Thorkildson P; Percival A; Lyons CR
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5042-7. PubMed ID: 15051894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
    Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
    Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved detection of bacterial antigens by latex agglutination after rapid extraction from body fluids.
    Smith LP; Hunter KW; Hemming VG; Fischer GW
    J Clin Microbiol; 1984 Nov; 20(5):981-4. PubMed ID: 6439735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
    Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J
    Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
    Henning LN; Carpenter S; Stark GV; Serbina NV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naturally acquired antibodies to Bacillus anthracis protective antigen in vultures of southern Africa.
    Turnbull PC; Diekmann M; Kilian JW; Versfeld W; De Vos V; Arntzen L; Wolter K; Bartels P; Kotze A
    Onderstepoort J Vet Res; 2008 Jun; 75(2):95-102. PubMed ID: 18788202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M; Roehrl MH; Basar E; Wang JY
    Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis.
    WRIGHT GG; PUZISS M; NEELY WB
    J Bacteriol; 1962 Mar; 83(3):515-22. PubMed ID: 14008433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on immunity in anthrax. IV. Factors influencing elaboration of the protective antigen of bacillus antracis in chemically defined media.
    PUZISS M; WRIGHT GG
    J Bacteriol; 1954 Oct; 68(4):474-82. PubMed ID: 13201552
    [No Abstract]   [Full Text] [Related]  

  • 54. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.
    Wui SR; Kim HK; Han JE; Kim JM; Kim YH; Chun JH; Cho YJ; Lee NG
    Int Immunopharmacol; 2011 Sep; 11(9):1195-204. PubMed ID: 21492746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [THE LATEX-FLAGELLA AGGLUTINATION].
    BADER RE
    Z Hyg Infektionskr; 1964 Dec; 150():199-210. PubMed ID: 14335620
    [No Abstract]   [Full Text] [Related]  

  • 57. Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics.
    Kulshreshtha P; Tiwari A; Priyanka ; Joon S; Sinha S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):185-93. PubMed ID: 26364143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Preparation and study of the anthrax protective antigen. II. Development of test preparations for the assessment of the quality of anthrax chemical vaccines and of the antigens obtained at various stages of its preparation].
    Kuz'mich MK; Derbin MI; Garin NS; Kravets ID; Shentsev IV; Tarumov VS; Gorlanov AA; Sadovoy NV; Fedorova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):94-8. PubMed ID: 827163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survey on experiences with latex-Chagas-test in various countries.
    Enders B; Hungerer KD; Zwisler O
    Tropenmed Parasitol; 1975 Jun; 26(2):252-60. PubMed ID: 808885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.